Muscle glycogen content in type 2 diabetes mellitus

American Journal of Physiology - Endocrinology and Metabolism

Volumn 287, Issue 5 50-5, 2004, Pages

  He, Jing ^a   Kelley, David E ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Insulin resistance; Intramyocellular lipid; Mitochondria; Skeletal muscle

Indexed keywords

GLYCOGEN; INSULIN; LIPID;

ADULT; ARTICLE; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE UTILIZATION; GLYCOGEN MUSCLE LEVEL; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; MUSCLE CELL; MUSCLE MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; VASTUS LATERALIS MUSCLE;

DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLYCOGEN; HOMEOSTASIS; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE FIBERS; MUSCLE, SKELETAL; OBESITY; REFERENCE VALUES;

EID: 6044264975     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00015.2004     Document Type: Article

References (44)

1. Boden G, Chen X, Ruiz J, White JV, and Rossetti L. Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93: 2438-2446, 1994.
2. Bogardus C, Lillioja S, Mott D, Reaven G, Kashiwagi A, and Foley J. Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. J Clin Invest 73: 800-805, 1984.
3. Bogardus C, Thuillez P, Ravussin E, Vasquez B, Narimiga M, and Azhar S. Effect of muscle glycogen depletion on in vivo insulin action in man. J Clin Invest 72: 1605-1610, 1983.
4. Bruce CR, Anderson MJ, Carey AL, Newman DG, Bonen A, Kriketos AD, Cooney GJ, and Hawley JA. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab 88: 5444-5451, 2003.
5. Bryson J, Phuyal J, Swan V, and Caterson I. Leptin has acute effects on glucose and lipid metabolism in both lean and gold thioglucose-obese mice. Am J Physiol Endocrinol Metab 277: E417-E422, 1999.
6. Carey P, Halliday J, Snaar J, Morris P, and Taylor R. Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects. Am J Physiol Endocrinol Metab 284: E688-E694, 2003.
7. Czech MP and Corvera S. Signaling mechanisms that regulate glucose transport. J Biol Sci 274: 1865-1868, 1999.
8. DeFronzo R, Jacot E, Jequier E, Maeder E, Wahren J, and Felber J. The effect of insulin on disposal of intravenous glucose. Diabetes 30: 1000-1007, 1981.
9. Flatt JP. Dietary fat, carbohydrate balance, and weight maintenance: effects of exercise. Am J Clin Nutr 45: 296-306, 1987.
10. Furnsinn C, Brunmair B, Meyer M, Neschen S, Furtmuller R, Roden M, Kuhnle H, Nowotny P, Schneider B, and Waldhausl W. Chronic and acute effects of thiazolidinediones BM13.1258 and BM.152054 on rat skeletal muscle glucose metabolism. Br J Pharmacol 128: 1141-1148, 1999.
11. Garcia-Roves P, Dong-Ho H, Song Z, Jones T, Hucker K, and Holloszy J. Prevention of glycogen supercompensation prolongs the increase in muscle GLUT4 after exercise. Am J Physiol Endocrinol Metab 285: E729-E736, 2003.
12. Goodpaster B, He J, Watkins S, and Kelley D. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86: 5755-5761, 2001.
13. Goodpaster BH and Kelley DE. Role of muscle in triglyceride metabolism. Curr Opin Lipidol 9: 231-236, 1998.
14. He J, Watkins S, and Kelley DE. Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50: 817-823, 2001.
15. Helge J and Dela F. Effect of training on muscle triacylglycerol and structural lipids: a relation to insulin sensitivity? Diabetes 52: 1881-1887, 2003.
16. Kelley D, Goodpaster B, Wing R, and Simoneau J. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol Endocrinol Metab 277: E1130-E1141, 1999.
17. Kelley D, He J, Menshikova E, and Ritov V. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes mellitus. Diabetes 51: 2944-2950, 2002.
18. Kelley D, Mokan M, and Mandarino L. Intracellular defects in glucose metabolism in obese patients with noninsulin-dependent diabetes mellitus. Diabetes 41: 698-706, 1992.
19. Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WG, and Bogardus C. Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance. J Clin Endocrinol Metab 62: 922-926, 1986.
20. Malenfant P, Tremblay A, Doucet E, Imbeault P, Simoneau JA, and Joanisse DR. Elevated intramyocellular lipid concentration in obese subjects is not reduced after diet and exercise training. Am J Physiol Endocrinol Metab 280: E632-E639, 2001.
21. Marshall S, Bacote V, and Traxinger R. Discovery of a metabolic pathway mediating desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266: 4706-4712, 1991.
22. Mootha V, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, and Groop LC. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273, 2003.
23. Mott DM, Lillloja S, and Bogardus C. Overnutrition induced decrease in insulin action for glucose storage: in vivo and in vitro in man. Metabolism 35: 160-165, 1986.
24. Obici S and Rossetti L. Minireview: nutrient sensing and the regulation of insulin action and energy balance. Endocrinology 144: 5172-5178, 2003.
25. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogradus C, Jenkins AB, and Storlien LH. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46: 983-988, 1997.
26. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, Landaker EJ, Goldfine AB, Mun E, DeFronzo R, Finlayson J, Kahn CR, and Mandarino LJ. Coordinated reduction in genes of oxidative metabolism in humans with insulin resistance and diabetes: potential roles of PGC1 and NRF-1. Proc Natl Acad Sci USA 100: 8466-8471, 2003.
27. Perseghin G, Price T, Falk-Petersen K, Roden M, Cline G, Gerow K, Rothman D, and Shulman G. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N Engl J Med 335: 1357-1362, 1996.
28. Perseghin G, Scifo P, DeCobelli F, Pagliato E, Battezzati A, Arcelloni C, Vanzulli A, Testolin G, Pozza G, DelMaschio A, and Luzi L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic patients. Diabetes 48: 1600-16066, 1999.
29. Petersen K, Befoy D, Dufour S, Dziura J, Ariyan C, Rothman D, DiPietro L, Cline G, and Shulman G. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140-1142, 2003.
30. Petersen KF, Dufour S, Befroy D, Garcia R, and Shulman G. Impaired mitochondrial activity in insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-671, 2004.
31. Pette D and Staron RS. Cellular and molecular diversities of mammalian skeletal muscle fibers. Rev Physiol Biochem Pharmacol 116: 1-76, 1990.
32. Phillips DW, Caddy S, Llic V, Frayn KN, Borthwick AC, and Taylor R. Intramuscular triglycerides and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism 45: 947-950, 1996.
33. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 85: 4426-4433, 2000.
34. Roch-Norlund AE, Bergstrom J, Castenfors H, and Hultman E. Muscle gycogen in patients with diabetes mellitus. Acta Med Scand 187: 445-453, 1970.
35. Ruderman NB, Saha AK, Vavvas D, and Witters LA. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol Endocrinol Metab 276: E1-E18, 1999.
36. Saltiel A. The molecular and physiological basis of insulin resistance: emerging implications for metabolic and cardivascular disease. J Clin Invest 106: 163-169, 2000.
37. Schrauwen P, Lichtenbelt WD, Saris WM, and Westerterp KR. Fat balance in obese subjects: role of glycogen stores. Am J Physiol Endocrinol Metab 274: E1027-E1033, 1998.
38. Schrauwen-Hinderling VB, Schrauwen P, Hesselink MK, van Engelshoven JM, Nicolay K, Saris WH, Kessels AG, and Kooi ME. The increase in intramyocellular lipid content is a very early response to training. J Clin Endocrinol Metab 88: 1610-1616, 2003.
39. Sherman W, Katz A, Cutler C, Withers R, and Ivy J. Glucose transport: locus of muscle insulin resistance in obese Zucker rats. Am J Physiol Endocrinol Metab 255: E374-E382, 1988.
40. Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, and Schulman RG. Quantitiation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322: 223-228, 1990.
41. Simon DK and Johns DR. Mitochondrial disorders: clinical and genetic features. Annu Rev Med 50: 111-127, 1999.
42. Simoneau JA, Veerkamp JH, Turcotte LP, and Kelley DE. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J 13: 2051-2060, 1999.
43. Thorburn A, Andrikopoulos S, and Proietto J. Defects in liver and muscle glycogen metabolism in neonatal and adult New Zealand obese mice. Metabolism 44: 1298-1302, 1995.
44. Thorburn AW, Gumbiner B, Bulacan F, Wallace P, and Henry RR. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest 85: 522-529, 1990.